AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer.

MLA

Leclerc, Julie, et al. “AXIN2 Germline Testing in a French Cohort Validates Pathogenic Variants as a Rare Cause of Predisposition to Colorectal Polyposis and Cancer.” Genes, Chromosomes & Cancer, vol. 62, no. 4, Apr. 2023, pp. 210–22. EBSCOhost, https://doi.org/10.1002/gcc.23112.

APA

Leclerc, J., Beaumont, M., Vibert, R., Pinson, S., Vermaut, C., Flament, C., Lovecchio, T., Delattre, L., Demay, C., Coulet, F., Guillerm, E., Hamzaoui, N., Benusiglio, P. R., Brahimi, A., Cornelis, F., Delhomelle, H., Fert, F. S., Fournier, B. P. J., Hovnanian, A., & Legrand, C. (2023). AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer. Genes, Chromosomes & Cancer, 62(4), 210–222. https://doi.org/10.1002/gcc.23112

Chicago

Leclerc, Julie, Marie Beaumont, Roseline Vibert, Stéphane Pinson, Catherine Vermaut, Cathy Flament, Tonio Lovecchio, et al. 2023. “AXIN2 Germline Testing in a French Cohort Validates Pathogenic Variants as a Rare Cause of Predisposition to Colorectal Polyposis and Cancer.” Genes, Chromosomes & Cancer 62 (4): 210–22. doi:10.1002/gcc.23112.